Role of Ultra-Rapid Acting Insulin in Managing Diabetes

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Diabetes Technology & Therapeutics

• Publication date

  2026-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/15209156251403447PMID 41622418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Real-World Incidence of Lung Malignancy and Chronic Obstructive Pulmonary Disease with Inhaled Insulin in People with Diabetes

  2026cited by this paper
• The Potential of Inhaled Insulin Therapy in Overcoming Treatment Barriers in People with Insulin-Treated Diabetes

  2026cited by this paper
• Impact of Inhaled Insulin Therapy on Hypoglycemia

  2026cited by this paper
• Dosing Afrezza: It’s Not that Complicated

  2026cited by this paper
• Pulmonary Safety and Clinical Considerations for Inhaled Insulin: A Comprehensive Review

  2026cited by this paper
• 30 Years of Developing Inhaled Insulin

  2026cited by this paper
• Potential Applications of Inhaled Insulin in Diabetic Ketoacidosis Prevention and During Exercise: Two Case Presentations

  2026cited by this paper
• Use of Inhaled Insulin with Automated Insulin Delivery Systems

  2026cited by this paper
• Overcoming Therapeutic Inertia with Inhaled Insulin Therapy

  2026cited by this paper
• Potential Role of Inhaled Insulin in the Management of Gestational Diabetes Mellitus and Pediatric Type 1 Diabetes

  2026cited by this paper
• Unmet Needs in Insulin-Treated Diabetes Management

  2026cited by this paper
• Safety of Inhaled Insulin in Adults with Diabetes

  2026cited by this paper
• Inhaled insulin in pregnancy: A case series supporting feasibility and clinical potential for pregnant people with diabetes

  2025cited by this paper
• Diabetes diagnosis based on glucose control levels and time until diagnosis: a regression discontinuity approach to assess the effect on direct healthcare costs

  2025cited by this paper
• A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes

  2025cited by this paper
• Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes: The INHALE-3 Extension Study

  2025cited by this paper
• The DERMIS Study: Methodologies, Results, and Implications for the Future.

  2024cited by this paper
• Time–Action Profile of Technosphere Insulin in Children with Type 1 Diabetes

  2023cited by this paper
• An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study

  2023cited by this paper
• Gaps Remain for Achieving HbA1c Targets for People with Type 1 or Type 2 Diabetes Using Insulin: Results from NHANES 2009–2020

  2023cited by this paper
• Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases

  2023cited by this paper
• Past, Present, and Future of Continuous Glucose Monitors

  2023cited by this paper
• Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis

  2022cited by this paper
• Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin Dosage

  2022cited by this paper
• Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.

  2022cited by this paper
• Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes

  2022cited by this paper
• Lingering Effects of Hyperglycemia in Recently Diagnosed Diabetes During Long-term Follow-up of the DCCT/EDIC and UKPDS Cohorts: More Evidence That Early Control Matters

  2021cited by this paper
• Ultra-Rapid-Acting Insulins: How Fast Is Really Needed?

  2021cited by this paper
• 100 years on: the impact of the discovery of insulin on clinical outcomes

  2021cited by this paper
• High Prevalence of Depressive Symptoms in Patients With Type 1 and Type 2 Diabetes in Developing Countries: Results From the International Diabetes Management Practices Study

  2020cited by this paper
• Comprehensive Pulmonary Safety Review of Inhaled Technosphere® Insulin in Patients with Diabetes Mellitus

  2020cited by this paper
• Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective.

  2019cited by this paper
• Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis.

  2019cited by this paper
• Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations

  2019cited by this paper
• Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

  2019influential reference
• Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice

  2018cited by this paper
• Optimal prandial timing of bolus insulin in diabetes management: a review

  2017cited by this paper
• Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control

  2016cited by this paper
• Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus

  2016cited by this paper
• Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial

  2015cited by this paper
• Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents

  2015cited by this paper
• Insulin stacking versus therapeutic accumulation: understanding the differences.

  2014cited by this paper
• The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

  2013cited by this paper
• Clinical utility of insulin and insulin analogs

  2013cited by this paper
• The pharmacokinetics and pharmacodynamics of rapid‐acting insulin analogues and their clinical consequences

  2012cited by this paper
• Needle Anxiety in Children With Type 1 Diabetes and Their Mothers

  2011cited by this paper
• The Relationship Between Diabetes Distress and Clinical Depression With Glycemic Control Among Patients With Type 2 Diabetes

  2010cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study

  2005cited by this paper
• Insulin: discovery and controversy.

  2002cited by this paper
• Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell Function

  1995cited by this paper
• Human insulin (Novo): chemistry and characteristics.

  1983cited by this paper
• Human insulin from recombinant DNA technology.

  1983cited by this paper

• No citing papers are available for this paper.